De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
UHS Overzicht aandelen
Universal Health Services, Inc. is via haar dochterondernemingen eigenaar en exploitant van ziekenhuizen voor acute zorg, poliklinieken en faciliteiten voor gedragsmatige gezondheidszorg.
| Sneeuwvlok Score | |
|---|---|
| Waardering | 5/6 |
| Toekomstige groei | 1/6 |
| Prestaties in het verleden | 4/6 |
| Financiële gezondheid | 4/6 |
| Dividenden | 0/6 |
Community Narratives
Create a narrativeNarratives bring a range of perspectives from our community.
Strategic Investments And Medicaid Programs Fuel Growth
Universal Health Services, Inc. Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | US$215.68 |
| 52 Week Hoogtepunt | US$243.25 |
| 52 Week Laag | US$119.90 |
| Bèta | 1.28 |
| 11 maand verandering | -5.88% |
| 3 maanden verandering | 19.40% |
| 1 Jaar Verandering | 70.65% |
| 33 jaar verandering | 65.36% |
| 5 jaar verandering | 47.59% |
| Verandering sinds IPO | 11,307.87% |
Recent nieuws en updates
Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down
Sep 26
Universal Health Services: Stock Has Lots Of Upside Runway
Sep 17Recent updates
Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down
Sep 26Universal Health Services: Stock Has Lots Of Upside Runway
Sep 17Investors Aren't Entirely Convinced By Universal Health Services, Inc.'s (NYSE:UHS) Earnings
Aug 10We Think Universal Health Services (NYSE:UHS) Can Stay On Top Of Its Debt
Jul 26Universal Health Services: An Underpriced Healthy Business
Jul 04Is Now The Time To Look At Buying Universal Health Services, Inc. (NYSE:UHS)?
Jun 25Returns At Universal Health Services (NYSE:UHS) Appear To Be Weighed Down
Jun 10This Is Why Universal Health Services, Inc.'s (NYSE:UHS) CEO Compensation Looks Appropriate
May 09Universal Health Services, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Predictions
Apr 26Market Cool On Universal Health Services, Inc.'s (NYSE:UHS) Earnings
Apr 17Universal Health Services, Inc. (NYSE:UHS) Just Reported And Analysts Have Been Lifting Their Price Targets
Mar 01Is Universal Health Services (NYSE:UHS) Using Too Much Debt?
Feb 20Universal Health Services (NYSE:UHS) Will Want To Turn Around Its Return Trends
Feb 05With Universal Health Services, Inc. (NYSE:UHS) It Looks Like You'll Get What You Pay For
Jan 09Is There An Opportunity With Universal Health Services, Inc.'s (NYSE:UHS) 48% Undervaluation?
Dec 13What Does Universal Health Services, Inc.'s (NYSE:UHS) Share Price Indicate?
Nov 02Capital Allocation Trends At Universal Health Services (NYSE:UHS) Aren't Ideal
Oct 15Universal Health Services (NYSE:UHS) Takes On Some Risk With Its Use Of Debt
Sep 28Universal Health Services: Seeking A Cure For Flat Performance
Sep 11Is Universal Health Services, Inc. (NYSE:UHS) Potentially Undervalued?
Jul 23Universal Health Services: Business Is On The Mend
Jul 12Returns On Capital Signal Tricky Times Ahead For Universal Health Services (NYSE:UHS)
Jul 10Here's Why Universal Health Services (NYSE:UHS) Has A Meaningful Debt Burden
Jun 26Calculating The Fair Value Of Universal Health Services, Inc. (NYSE:UHS)
May 28Should You Think About Buying Universal Health Services, Inc. (NYSE:UHS) Now?
Apr 23Universal Health Services (NYSE:UHS) Could Be Struggling To Allocate Capital
Apr 07Here's Why Universal Health Services (NYSE:UHS) Has A Meaningful Debt Burden
Mar 23Universal Health Services Q4 2022 Earnings Preview
Feb 24Is Universal Health Services, Inc. (NYSE:UHS) Trading At A 31% Discount?
Feb 14Universal Health: Retain Buy As Systematic Defensive Overlay
Feb 04Universal Health Services declares $0.20 dividend
Jan 18Universal Health Services (NYSE:UHS) Will Be Hoping To Turn Its Returns On Capital Around
Jan 05Universal Health Services upgraded at Wells Fargo on improving operating environment
Jan 03Is It Too Late To Consider Buying Universal Health Services, Inc. (NYSE:UHS)?
Dec 21Is Universal Health Services (NYSE:UHS) Using Too Much Debt?
Dec 08Universal Health Services: Attractive Even In Light Of Cost Concerns
Nov 14Is There An Opportunity With Universal Health Services, Inc.'s (NYSE:UHS) 50% Undervaluation?
Nov 10Universal Health net income falls 19% but still good enough for a bottom line beat
Oct 25Rendement voor aandeelhouders
| UHS | US Healthcare | US Markt | |
|---|---|---|---|
| 7D | -6.2% | -1.2% | 0.3% |
| 1Y | 70.6% | 8.2% | 32.4% |
Rendement versus industrie: UHS overtrof de US Healthcare industrie, die het afgelopen jaar een rendement 10.8 % opleverde.
Rendement versus markt: UHS overtrof de US markt, die het afgelopen jaar een rendement opleverde van 34.1 %.
Prijsvolatiliteit
| UHS volatility | |
|---|---|
| UHS Average Weekly Movement | 4.4% |
| Healthcare Industry Average Movement | 7.1% |
| Market Average Movement | 6.4% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.1% |
Stabiele aandelenkoers: UHS heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 4% ) van UHS is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1978 | 85,025 | Marc Miller | www.uhs.com |
Universal Health Services, Inc. is via haar dochterondernemingen eigenaar en exploitant van ziekenhuizen voor acute zorg, poliklinieken en voorzieningen voor gedragsmatige gezondheidszorg. Het bedrijf opereert via de segmenten Acute Care Hospital Services en Behavioral Health Care Services. De ziekenhuizen van het bedrijf bieden algemene en gespecialiseerde chirurgie, interne geneeskunde, verloskunde, spoedeisende hulp, radiologie, oncologie, diagnostische en coronaire zorg, pediatrische diensten, apotheekdiensten en/of diensten op het gebied van gedragsgezondheid.
Universal Health Services, Inc. Samenvatting
| UHS fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | US$14.39b |
| Inkomsten(TTM) | US$934.19m |
| Inkomsten(TTM) | US$15.02b |
15.4x
Koers/Winstverhouding1.0x
P/S-verhoudingIs UHS overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| UHS resultatenrekening (TTM) | |
|---|---|
| Inkomsten | US$15.02b |
| Kosten van inkomsten | US$8.85b |
| Brutowinst | US$6.17b |
| Overige uitgaven | US$5.24b |
| Inkomsten | US$934.19m |
Laatst gerapporteerde inkomsten
Jun 30, 2024
Volgende inkomensdatum
Oct 24, 2024
| Winst per aandeel (EPS) | 14.00 |
| Brutomarge | 41.09% |
| Nettowinstmarge | 6.22% |
| Schuld/Eigen Vermogen Verhouding | 69.3% |
Hoe presteerde UHS op de lange termijn?
Bekijk historische prestaties en vergelijking